Elanco Animal Health (ELAN) Net Equity Issued and Repurchased (2020 - 2021)
Elanco Animal Health's (ELAN) quarterly Net Equity Issued and Repurchased came in at $500.0 million in Q4 2021, down 59.02% quarter-over-quarter from $1.2 billion in Q1 2020.
Powered by 
Analysis
Elanco Animal Health (ELAN) Net Equity Issued and Repurchased (2020 - 2021) Analysis & Trends
Elanco Animal Health has disclosed Net Equity Issued and Repurchased across 2 years of filings, most recently posting $500.0 million for Q4 2021.
- In Q4 2021, Net Equity Issued and Repurchased changed N/A year-over-year to $500.0 million; the TTM figure through Dec 2021 stood at $500.0 million (down 59.02% YoY), while the FY2022 annual figure was $425.0 million, down 15.0% from the prior year.
- Net Equity Issued and Repurchased came in at $500.0 million for Q4 2021 at Elanco Animal Health, down from $1.2 billion in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $1.2 billion in Q1 2020 to a low of $500.0 million in Q4 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.46 Bn | 40.26 Bn | 779.09 Mn | - |
| 2 | Zoetis | 30.65 Bn | 28.98 Bn | 1.05 Bn | - |
| 3 | Elanco Animal Health | 11.82 Bn | 11.29 Bn | 798.00 Mn | - |
| 4 | Phibro Animal Health | 1.50 Bn | 1.42 Bn | 134.40 Mn | - |
| 5 | Immucell | 89.92 Mn | 81.06 Mn | 2.44 Mn | - |
| 6 | Zhengye Biotechnology Holding | 75.29 Mn | 68.19 Mn | - | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | 105,646.00 |